Vanda Pharmaceuticals, Inc.
Industry
- Pharmaceuticals
- Specialty Pharmaceuticals
- Vaccines
- Biotechnology
- Antisense, Oligonucleotides
Latest on Vanda Pharmaceuticals, Inc.
The US Food and Drug Administration will not revoke abbreviated new drug application approvals for generic versions of Vanda Pharmaceuticals ’ Hetlioz (tasimelteon) 20mg capsules held by Teva and
The US Food and Drug Administration will not revoke abbreviated new drug application approvals for generic versions of Vanda Pharmaceuticals’ Hetlioz (tasimelteon) 20mg capsules held by Teva and MSN L
Neurocrine Updates On Crenessity Launch Neurocrine Biosciences announced encouraging early sales for its new commercial product, Crenessity (crinecerfont), in its first full quarter of launch. Crene
The US Food and Drug Administration’s missed user fee goal date for Stealth BioTherapeutics ’ Barth syndrome drug elamipretide may be another signal of drug regulatory work slowed by recent layoffs a